Learn Why Glenn Russell Dubin’s Highbridge Capital Management Llc Purchased Egalet Corp Stake?

July 17, 2017 - By test

 Learn Why Glenn Russell Dubin's Highbridge Capital Management Llc Purchased Egalet Corp Stake?

Investors sentiment increased to 1.89 in 2016 Q4. Its up 0.68, from 1.21 in 2016Q3. It improved, as 6 investors sold Egalet Corp shares while 13 reduced holdings. 17 funds opened positions while 19 raised stakes. 14.72 million shares or 1.09% less from 14.88 million shares in 2016Q3 were reported.

Keybank National Association Oh holds 0% or 31,601 shares in its portfolio. Janney Montgomery Scott Llc holds 0.01% or 48,713 shares in its portfolio. Moreover, Blackrock Advsr Limited Liability Corporation has 0% invested in Egalet Corp (NASDAQ:EGLT). Paloma Prtnrs Mngmt holds 11,666 shares. Legal General Gp Public Ltd reported 3,886 shares. Blackrock Fund Advisors has 0% invested in Egalet Corp (NASDAQ:EGLT). Tiaa Cref Investment Management Lc has invested 0% of its portfolio in Egalet Corp (NASDAQ:EGLT). Fmr Ltd Limited Liability Company has 3.76 million shares for 0% of their portfolio. Trexquant Inv Ltd Partnership has invested 0.01% of its portfolio in Egalet Corp (NASDAQ:EGLT). Moreover, State Street has 0% invested in Egalet Corp (NASDAQ:EGLT). Marshall Wace Limited Liability Partnership invested 0% in Egalet Corp (NASDAQ:EGLT). Susquehanna Intll Grp Llp reported 0% of its portfolio in Egalet Corp (NASDAQ:EGLT). Deutsche Bank Ag invested 0% in Egalet Corp (NASDAQ:EGLT). Savings Bank Of Mellon Corp owns 82,414 shares or 0% of their US portfolio. California State Teachers Retirement has 45,546 shares for 0% of their portfolio.

The New Glenn Russell Dubin’s Highbridge Capital Management Llc Holding in Egalet Corp

Highbridge Capital Management Llc reported SC 13G form with the SEC for Egalet Corp. Access it here: 000090266417002950. As reported by Glenn Russell Dubin’s Highbridge Capital Management Llc, the filler owns 9.58% or 4,120,800 shares of the Health Care–company.

Egalet Corp stake is new for [reportingPerson]. Date of activity: July 6, 2017. This shows Glenn Russell Dubin’s Highbridge Capital Management Llc’s positive view for Egalet Corp. For a hedge fund managing $32.39 billion in assets and having 310+ experts this is interesting position.

The hedge fund is investor in the Health Care sector. In the manager’s last 13-F, we saw 12% of Glenn Russell Dubin’s Highbridge Capital Management Llc’s portfolio is in the sector.

Egalet Corp Institutional Sentiment

Filings show 39 investors own Egalet Corp. The ownership in Q3 2015 is low, at 65.29 % of the outstanding shares. This is increased by 12477645. 17196177 were owned by these investors. 15 funds opened new Egalet Corp stakes, 13 increased positions. There were 9 that closed positions and 6 reduced them.

Apis Capital Advisors Llc is an investor bullish on Egalet Corp, owning 16000 shares as of Q3 2015 for 0.29% of its portfolio. Sphera Funds Management Ltd owns 325000 shares or 0.55% of its portfolio. NY Broadfin Capital Llc have 0.83% of its portfolio for 1134750 shares. Further, Wall Street Associates reported stake worth 0.83% of its portfolio. The CA Venbio Select Advisor Llc owns 440606 shares. Egalet Corp is 1.51% of its portfolio.

Business Profile

Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company’s products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company’s product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company’s product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company’s product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company’s product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.

SEC Form 13G.

Glenn Russell Dubin’s Highbridge Capital Management Llc website.

About 533,469 shares traded. Egalet Corp (NASDAQ:EGLT) has declined 46.67% since July 17, 2016 and is downtrending. It has underperformed by 63.37% the S&P500.

Egalet Corporation is a specialty pharmaceutical company. The company has market cap of $36.65 million. The Firm is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. It currently has negative earnings. The Company’s products include OXAYDO and SPRIX Nasal Spray.

Egalet Corp (NASDAQ:EGLT) Ratings Coverage

Among 2 analysts covering Egalet Ltd (NASDAQ:EGLT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Egalet Ltd has $1500 highest and $6 lowest target. $7’s average target is 363.58% above currents $1.51 stock price. Egalet Ltd had 6 analyst reports since November 4, 2015 according to SRatingsIntel. Cantor Fitzgerald initiated Egalet Corp (NASDAQ:EGLT) on Wednesday, November 4 with “Buy” rating. The firm has “Buy” rating by JMP Securities given on Friday, June 9. The rating was maintained by JMP Securities with “Market Outperform” on Friday, July 14. Cantor Fitzgerald maintained the stock with “Buy” rating in Tuesday, June 13 report. Cantor Fitzgerald maintained the shares of EGLT in report on Wednesday, June 7 with “Buy” rating. The firm earned “Buy” rating on Thursday, June 1 by Cantor Fitzgerald.

More notable recent Egalet Corp (NASDAQ:EGLT) news were published by: Nasdaq.com which released: “Mid-Day Market Update: Crude Oil Up Over 2%; Egalet Shares Plummet” on July 06, 2017, also Prnewswire.com with their article: “Egalet Corporation Announces Changes to Board of Directors” published on April 10, 2017, Prnewswire.com published: “Egalet Announces Proposed Public Offering of Common Stock and Warrants” on July 05, 2017. More interesting news about Egalet Corp (NASDAQ:EGLT) were released by: Streetinsider.com and their article: “Form 8-K Egalet Corp For: Jun 20” published on June 20, 2017 as well as Investorplace.com‘s news article titled: “3 Stocks to Watch on Thursday: Egalet Corp (EGLT), Herman Miller, Inc. (MLHR …” with publication date: July 06, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.